HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.
COVID-19 Impact on World-Wide Pharma Companies
During C0VID-19, industry growth has slow-down, delay in approvals, and self-sufficiency in pharm-production supply chain and trend changes in consumption of health-market products along with ethical crisis could be anticipated as long-term impacts of COVID-19 pandemic on the pharmaceutical sector in both global and local levels.
PDDS 2022 Speakers
Victoria Demina
NEUWAY Pharma GmbH, GermanySubmit your abstract Today
Title : Drug Delivery to the Brain using Engineered Protein Capsules (EnPCs®)
Victoria Demina, NEUWAY Pharma GmbH, Germany
Title : NEWER ADVANCES OF ANTI –HIV THERAPY
Bhuvanesh baniya, Jai Narain Vyas University Jodhpur, India
Title : Insulin Resistance Associated Alzheimer Disease Condition in Rats is ameliorated via Epigenetic Regulation and Autophagy Modulation
Violina Kakoty, Birla Institute of Technology and Science-Pilani, India
Title : SELF MICROEMULSIFYING SYSTEMS BASED TOPICAL LIPSTICK OF ANTIFUNGAL AGENT
Bhupendra Gopalbhai Prajapati, Ganpat University, Shree S.K.Patel College of Pharmaceutical Education and Research, India
Title : Sol-gel, phase inversion precipitation and microfluidic systems for controlled delivery of pharmaceuticals and bioactive compounds in nutraceuticals and nano nutraceuticals
Sandile Phinda Songca, University of KwaZulu-Natal, South Africa
Title : The e?ects of Anethum graveolens (dill) supplementation on lipid profile and glycemic control: A systematic review and meta-analysis of randomized controlled trials
Seyed Mohammad Mousavi, Tehran University of Medical Sciences, Tehran, Iran., Iran (Islamic Republic of)